These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21471456)

  • 1. Alternative mechanisms of receptor editing in autoreactive B cells.
    Kalinina O; Doyle-Cooper CM; Miksanek J; Meng W; Prak EL; Weigert MG
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7125-30. PubMed ID: 21471456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
    Makdasi E; Fischel R; Kat I; Eilat D
    J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA.
    Li Z; Schettino EW; Padlan EA; Ikematsu H; Casali P
    Eur J Immunol; 2000 Jul; 30(7):2015-26. PubMed ID: 10940891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain editors of anti-DNA receptors in human B cells.
    Kalinina O; Wang Y; Sia K; Radic M; Cazenave PA; Weigert M
    J Exp Med; 2014 Feb; 211(2):357-64. PubMed ID: 24470445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo expression of a nephritogenic Ig heavy chain determinant: pathogenic autoreactivity requires permissive light chains.
    Cooperstone BG; Rahman MM; Rudolph EH; Foster MH
    Immunol Cell Biol; 2001 Jun; 79(3):222-30. PubMed ID: 11380674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion.
    Doyle CM; Han J; Weigert MG; Prak ET
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11264-9. PubMed ID: 16847259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern.
    Li Y; Li H; Ni D; Weigert M
    J Exp Med; 2002 Dec; 196(12):1543-52. PubMed ID: 12486097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor editing: an approach by autoreactive B cells to escape tolerance.
    Gay D; Saunders T; Camper S; Weigert M
    J Exp Med; 1993 Apr; 177(4):999-1008. PubMed ID: 8459227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells.
    Sekiguchi DR; Eisenberg RA; Weigert M
    J Exp Med; 2003 Jan; 197(1):27-39. PubMed ID: 12515811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light chain contribution to specificity in anti-DNA antibodies.
    Ibrahim SM; Weigert M; Basu C; Erikson J; Radic MZ
    J Immunol; 1995 Sep; 155(6):3223-33. PubMed ID: 7673735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactivity and allelic inclusion in a B cell nuclear transfer mouse.
    Gerdes T; Wabl M
    Nat Immunol; 2004 Dec; 5(12):1282-7. PubMed ID: 15516926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing.
    Chen C; Nagy Z; Prak EL; Weigert M
    Immunity; 1995 Dec; 3(6):747-55. PubMed ID: 8777720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDR3 regions in the preimmune VH B cell repertoire of lpr mice.
    Alarcón-Riquelme ME; Fernández C
    Clin Exp Immunol; 1995 Jul; 101(1):73-7. PubMed ID: 7621595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing.
    Wakui M; Kim J; Butfiloski EJ; Morel L; Sobel ES
    J Immunol; 2004 Dec; 173(12):7368-76. PubMed ID: 15585861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen receptor editing in anti-DNA transitional B cells deficient for surface IgM.
    Kiefer K; Nakajima PB; Oshinsky J; Seeholzer SH; Radic M; Bosma GC; Bosma MJ
    J Immunol; 2008 May; 180(9):6094-106. PubMed ID: 18424731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance.
    Prak EL; Trounstine M; Huszar D; Weigert M
    J Exp Med; 1994 Nov; 180(5):1805-15. PubMed ID: 7964462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.